REQUEST A DEMO
Total
USD $0.00
Search more companies

Suntar Eco-City Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Suntar Eco-City Limited Profile Updated: May 03, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Suntar Eco-City Limited operates as an investment holding company engaged in manufacturing hormone-type pharmaceutical products including gibberellic acids and validamycin. The company, through its subsidiary Xi’an Reyphon Pharmaceutical Co., Ltd, manufactures and distributes pharmaceutical ingredient products. Suntar Eco-City Limited expanded its business portfolio to eco-tourism real estate development and management. The company was incorporated in 2006 formerly known as Reyphon Agriceutical Limited.

Legal Address
Southern Industrial Development Zone,Xin'Gan County,Jiangxi Province
Jian; Jiangxi; Postal Code: 331307

Contact Details: Purchase the Suntar Eco-City Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Suntar Eco-City Limited report to view the information.
Financial Auditors:
Purchase the Suntar Eco-City Limited report to view the information.
Incorporation Date:
September 22, 2006
Key Executives
Purchase this report to view the information.
Chairman/Director
Ownership Details
Purchase this report to view the information.
75.23%
Company Performance
Financial values in the chart are available after Suntar Eco-City Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-25.02%
Total operating revenue
-15.42%
Operating profit (EBIT)
88.71%
EBITDA
54.21%
Net Profit (Loss) for the Period
N/A
Total assets
-12.56%
Total equity
0.86%
Operating Profit Margin (ROS)
38.34%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
1.24%
Cash Ratio
1.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?